<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Eyes on Research

BCVA, OCT, IOP, and Visual Field Testing in Clinical Trials: How to Standardize Across Sites

20/20 Onsite

What Sponsors Need from Decentralized Clinical Trial Platforms for Ophthalmic Endpoints

20/20 Onsite

Site Initiation Visits for Clinical Trials: Ocular Endpoint Planning and Staff Certification

By 20/20 Onsite

Read More

At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense

By 20/20 Onsite

At-home clinical trials have the potential to improve how research studies are conducted and the level of participation they receive. Learn more about this option and whether it’s appropriate for... Read More

Hybrid Clinical Trials: How to Split Ophthalmic Visits Across Home, Hub, and Site

By 20/20 Onsite

Hybrid clinical trials combine traditional site-based research with decentralized trial (DCT) elements. These can include remote monitoring via apps and wearable technology, as well as virtual... Read More

2025 Recap: How 20/20 Onsite Drove Clinical Research Innovation by Transforming Patient Retention, Trial Efficiency, and Sponsor Confidence

By 20/20 Onsite

The most powerful shift in clinical research this year:Bringing the clinic to the patient is no longer optional; it's essential for patient enrollment and retention. 2025 proved that sponsors don't... Read More

Improving Diversity in Clinical Trials: How Mobile Clinics Remove Barriers to Participation

By 20/20 Onsite

Why Diversity in Clinical Trials Remains a Critical Gap Diversity in clinical trials is vital to ensure treatments are safe for everyone. Clinical trial participants come from all backgrounds,... Read More

Virtual Clinical Trials: Feasibility for BCVA, OCT, IOP

By 20/20 Onsite

BCVA can partially work in a virtual setting with validated digital tools and telemedicine oversight, but usually still benefits from a controlled, in-person environment. OCT essentially requires... Read More

Why Clinical Trial Demographics Don’t Match Real-World Populations

By 20/20 Onsite

When an enrolled trial population doesn't reflect how a condition is actually treated in the real world, the consequences show up well after approval: narrower labels, closer safety scrutiny, and... Read More

How Travel Burden Affects Clinical Trial Enrollment and Dropout, and How to Cut It by 82%

By 20/20 Onsite

Travel burden slows clinical trial enrollment and drives dropout. In CISCRP's 2025 survey of 4,415 study participants, having to travel to the study clinic was the top source of disruption, named by... Read More